124 related articles for article (PubMed ID: 6353268)
1. Clinical symptomatology and computer analyzed EEG before, during and after anxiolytic therapy of alcohol withdrawal patients.
Saletu M; Saletu B; Grünberger J; Mader R; Karobath M
Neuropsychobiology; 1983; 9(2-3):119-34. PubMed ID: 6353268
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of anxiety with prazepam, 40 mg. A controlled study versus lorazepam].
Danion JM; Brion S; Escande M; Ropert R; Sacquepee L; Singer L; Scotto JC
Encephale; 1984; 10(3):135-8. PubMed ID: 6389091
[TBL] [Abstract][Full Text] [Related]
3. [Value of prazepam drops in the brief treatment of anxiety disorders].
Ansseau M; Von Frenckell R
Encephale; 1991; 17(4):291-4. PubMed ID: 1959497
[TBL] [Abstract][Full Text] [Related]
4. Duration of benzodiazepine clinical activity: lack of direct relationship with plasma half-life. A comparison of single vs divided dosage schedules of prazepam.
Ansseau M; Doumont A; von Frenckell R; Collard J
Psychopharmacology (Berl); 1984; 84(3):293-8. PubMed ID: 6151206
[TBL] [Abstract][Full Text] [Related]
5. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
6. Classification and assessment of cerebral bioavailability of lopirazepam (D-12524) by quantitative EEG and psychometric analysis.
Saletu B; Grünberger J; Linzmayer L; Stadler R
Arzneimittelforschung; 1980; 30(3):513-8. PubMed ID: 6104496
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
Lemoine P; Touchon J; Billardon M
Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
[TBL] [Abstract][Full Text] [Related]
8. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
9. A multi-centre comparison of prazepam and diazepam in the treatment of anxiety.
Dorman T
Pharmatherapeutica; 1983; 3(6):433-40. PubMed ID: 6353434
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
[TBL] [Abstract][Full Text] [Related]
11. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety].
Guelfi JD; Lancrenon S; Millet V
Encephale; 1993; 19(5):547-52. PubMed ID: 8306923
[TBL] [Abstract][Full Text] [Related]
12. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
Saletu B; Grünberger J; Linzmayer L
Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
14. Prazepam and lorazepam, two new benzodiazepines.
Greenblatt DJ; Shader RI
N Engl J Med; 1978 Dec; 299(24):1342-4. PubMed ID: 30899
[No Abstract] [Full Text] [Related]
15. Double-blind comparison of lorazepam and chlordiazepoxide in the treatment of the acute alcohol abstinence syndrome.
Solomon J; Rouck LA; Koepke HH
Clin Ther; 1983; 6(1):52-8. PubMed ID: 6370437
[TBL] [Abstract][Full Text] [Related]
16. A double-blind comparison of prazepam with diazepam, chlorazepate dipotassium and placebo in anxious out-patients.
Fabre LF; McLendon DM; Mallette A
J Int Med Res; 1979; 7(2):147-51. PubMed ID: 39012
[TBL] [Abstract][Full Text] [Related]
17. [Prazepam drops versus 10 mg prazepam tablets in anxious patients in ambulatory care].
Chabannes JP; Lemoine P
Therapie; 1990; 45(6):467-70. PubMed ID: 2080484
[TBL] [Abstract][Full Text] [Related]
18. Compared efficacy of prazepam and clomipramine in major depression with anxiety: a multicenter controlled study.
Lemoine P; Boulenger JP; Caillard V; Tanne N; Bonnet D
Pharmacopsychiatry; 1991 Sep; 24(5):175-9. PubMed ID: 1775523
[TBL] [Abstract][Full Text] [Related]
19. Fast withdrawal from benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-controlled trial.
Petrovic M; Pevernagie D; Mariman A; Van Maele G; Afschrift M
Eur J Clin Pharmacol; 2002 Jan; 57(11):759-64. PubMed ID: 11868796
[TBL] [Abstract][Full Text] [Related]
20. Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364.
Saletu B; Grünberger J; Cepko H
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):421-37. PubMed ID: 2888736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
